| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 54 | 2026 | 692 | 8.240 |
Why?
|
| DNA Methylation | 49 | 2026 | 690 | 6.380 |
Why?
|
| Mucin-5B | 28 | 2026 | 234 | 4.710 |
Why?
|
| Epigenesis, Genetic | 32 | 2026 | 693 | 3.830 |
Why?
|
| Asthma | 23 | 2024 | 1797 | 2.690 |
Why?
|
| Sarcoidosis, Pulmonary | 5 | 2026 | 98 | 2.500 |
Why?
|
| Lung | 44 | 2026 | 4116 | 2.200 |
Why?
|
| Gene Expression Profiling | 27 | 2026 | 1777 | 1.740 |
Why?
|
| Macrophages | 13 | 2026 | 1507 | 1.650 |
Why?
|
| Gene Expression Regulation | 19 | 2026 | 2601 | 1.620 |
Why?
|
| Idiopathic Interstitial Pneumonias | 4 | 2020 | 44 | 1.480 |
Why?
|
| Genome-Wide Association Study | 26 | 2026 | 1430 | 1.470 |
Why?
|
| Gene Expression | 20 | 2022 | 1478 | 1.340 |
Why?
|
| Transcriptome | 10 | 2026 | 1043 | 1.330 |
Why?
|
| Genetic Predisposition to Disease | 25 | 2026 | 2399 | 1.290 |
Why?
|
| Lipopolysaccharides | 9 | 2013 | 858 | 1.290 |
Why?
|
| Immunity, Innate | 11 | 2022 | 835 | 1.270 |
Why?
|
| Prenatal Exposure Delayed Effects | 13 | 2024 | 655 | 1.210 |
Why?
|
| Environmental Exposure | 8 | 2021 | 578 | 1.200 |
Why?
|
| Nasal Mucosa | 6 | 2024 | 112 | 1.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 21 | 2021 | 751 | 1.170 |
Why?
|
| Quantitative Trait Loci | 9 | 2026 | 381 | 1.140 |
Why?
|
| Bronchioles | 2 | 2026 | 29 | 1.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 6 | 2026 | 638 | 1.050 |
Why?
|
| Lung Diseases | 5 | 2022 | 782 | 1.040 |
Why?
|
| Humans | 180 | 2026 | 145750 | 1.030 |
Why?
|
| Promoter Regions, Genetic | 13 | 2026 | 1247 | 1.000 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2026 | 118 | 0.970 |
Why?
|
| Bleomycin | 11 | 2026 | 255 | 0.960 |
Why?
|
| Epigenomics | 8 | 2025 | 117 | 0.960 |
Why?
|
| Respiratory Mucosa | 10 | 2025 | 322 | 0.960 |
Why?
|
| Cytokines | 10 | 2021 | 2069 | 0.960 |
Why?
|
| DNA | 10 | 2022 | 1437 | 0.940 |
Why?
|
| Polymorphism, Single Nucleotide | 19 | 2026 | 2181 | 0.880 |
Why?
|
| Granuloma | 2 | 2026 | 97 | 0.880 |
Why?
|
| Cell Communication | 2 | 2026 | 328 | 0.860 |
Why?
|
| Genome, Human | 6 | 2020 | 422 | 0.860 |
Why?
|
| Male | 106 | 2026 | 72992 | 0.840 |
Why?
|
| Genetic Variation | 11 | 2019 | 976 | 0.830 |
Why?
|
| Chagas Cardiomyopathy | 2 | 2015 | 27 | 0.790 |
Why?
|
| Berylliosis | 3 | 2022 | 202 | 0.780 |
Why?
|
| Toll-Like Receptor 4 | 7 | 2014 | 276 | 0.780 |
Why?
|
| Proprotein Convertases | 1 | 2023 | 16 | 0.780 |
Why?
|
| Case-Control Studies | 20 | 2026 | 3634 | 0.770 |
Why?
|
| MicroRNAs | 8 | 2024 | 686 | 0.770 |
Why?
|
| RNA | 9 | 2022 | 912 | 0.750 |
Why?
|
| Biomarkers | 11 | 2022 | 4302 | 0.750 |
Why?
|
| Female | 101 | 2026 | 79025 | 0.750 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2013 | 42 | 0.740 |
Why?
|
| Bacteremia | 3 | 2013 | 222 | 0.720 |
Why?
|
| Sarcoidosis | 2 | 2021 | 163 | 0.690 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2023 | 920 | 0.680 |
Why?
|
| Pulmonary Fibrosis | 7 | 2026 | 395 | 0.670 |
Why?
|
| Middle Aged | 54 | 2026 | 36297 | 0.660 |
Why?
|
| Fetal Blood | 11 | 2024 | 327 | 0.640 |
Why?
|
| Adiposity | 6 | 2024 | 532 | 0.630 |
Why?
|
| RNA, Messenger | 14 | 2024 | 2805 | 0.620 |
Why?
|
| Animals | 61 | 2026 | 38100 | 0.620 |
Why?
|
| Phenotype | 12 | 2025 | 3170 | 0.620 |
Why?
|
| Mice | 41 | 2026 | 18357 | 0.610 |
Why?
|
| Signal Transduction | 14 | 2022 | 5223 | 0.580 |
Why?
|
| CpG Islands | 12 | 2024 | 171 | 0.580 |
Why?
|
| Mucins | 1 | 2019 | 75 | 0.570 |
Why?
|
| Maternal Exposure | 5 | 2024 | 189 | 0.560 |
Why?
|
| Lung Diseases, Interstitial | 5 | 2023 | 664 | 0.550 |
Why?
|
| Guanine | 4 | 2002 | 85 | 0.530 |
Why?
|
| Cilia | 3 | 2022 | 173 | 0.530 |
Why?
|
| Epithelial Cells | 7 | 2022 | 1134 | 0.520 |
Why?
|
| Placenta | 5 | 2023 | 787 | 0.510 |
Why?
|
| Diabetes, Gestational | 2 | 2018 | 306 | 0.500 |
Why?
|
| Adult | 50 | 2026 | 40867 | 0.500 |
Why?
|
| Pediatric Obesity | 4 | 2020 | 638 | 0.490 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2018 | 574 | 0.490 |
Why?
|
| Alveolitis, Extrinsic Allergic | 3 | 2022 | 93 | 0.490 |
Why?
|
| Aged | 36 | 2026 | 26212 | 0.490 |
Why?
|
| Air Pollutants | 4 | 2024 | 406 | 0.480 |
Why?
|
| Gram-Positive Bacteria | 1 | 2016 | 48 | 0.470 |
Why?
|
| Enterobacteriaceae | 2 | 2013 | 44 | 0.470 |
Why?
|
| Th2 Cells | 2 | 2018 | 175 | 0.470 |
Why?
|
| Methamphetamine | 1 | 2017 | 74 | 0.470 |
Why?
|
| Trypanosoma cruzi | 2 | 2015 | 39 | 0.470 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 778 | 0.470 |
Why?
|
| Genetic Loci | 4 | 2026 | 267 | 0.460 |
Why?
|
| Pregnancy | 26 | 2025 | 7215 | 0.460 |
Why?
|
| Autoimmunity | 5 | 2026 | 933 | 0.450 |
Why?
|
| Inflammation | 8 | 2024 | 2883 | 0.440 |
Why?
|
| Forkhead Transcription Factors | 2 | 2017 | 209 | 0.440 |
Why?
|
| Hypothalamus | 4 | 1997 | 163 | 0.440 |
Why?
|
| E2F1 Transcription Factor | 2 | 2012 | 68 | 0.440 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2013 | 125 | 0.430 |
Why?
|
| Matrix Metalloproteinase 7 | 2 | 2021 | 25 | 0.430 |
Why?
|
| Child | 33 | 2026 | 22738 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2026 | 3937 | 0.410 |
Why?
|
| Somatostatin | 4 | 1997 | 53 | 0.390 |
Why?
|
| X-Box Binding Protein 1 | 2 | 2026 | 16 | 0.390 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 293 | 0.390 |
Why?
|
| Thyrotropin-Releasing Hormone | 4 | 1997 | 11 | 0.380 |
Why?
|
| Sequence Analysis, RNA | 6 | 2026 | 442 | 0.380 |
Why?
|
| Smoking | 9 | 2022 | 1477 | 0.380 |
Why?
|
| Genotype | 8 | 2025 | 1857 | 0.380 |
Why?
|
| Disease Progression | 6 | 2024 | 2865 | 0.380 |
Why?
|
| Animal Husbandry | 4 | 2021 | 33 | 0.380 |
Why?
|
| Antigens, Protozoan | 1 | 2012 | 32 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 440 | 0.370 |
Why?
|
| H-2 Antigens | 1 | 2012 | 111 | 0.360 |
Why?
|
| Mice, Inbred Strains | 5 | 2016 | 396 | 0.360 |
Why?
|
| Chromosomes, Mammalian | 2 | 2011 | 28 | 0.350 |
Why?
|
| Islets of Langerhans | 3 | 2024 | 847 | 0.350 |
Why?
|
| Urban Population | 1 | 2015 | 494 | 0.350 |
Why?
|
| Air Pollution | 3 | 2022 | 315 | 0.340 |
Why?
|
| Ozone | 1 | 2012 | 116 | 0.340 |
Why?
|
| Macrophage Activation | 2 | 2011 | 181 | 0.340 |
Why?
|
| Myocarditis | 1 | 2012 | 102 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 14 | 2026 | 5992 | 0.330 |
Why?
|
| RNA Interference | 5 | 2016 | 475 | 0.330 |
Why?
|
| Hedgehog Proteins | 3 | 2022 | 200 | 0.330 |
Why?
|
| Hypersensitivity | 3 | 2016 | 254 | 0.330 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 202 | 0.330 |
Why?
|
| Occupational Exposure | 4 | 2018 | 355 | 0.320 |
Why?
|
| Fluorocarbons | 2 | 2023 | 120 | 0.320 |
Why?
|
| Environmental Pollutants | 2 | 2023 | 139 | 0.320 |
Why?
|
| Genomics | 6 | 2023 | 831 | 0.320 |
Why?
|
| Fucosyltransferases | 2 | 2022 | 33 | 0.310 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 420 | 0.310 |
Why?
|
| Cysts | 2 | 2022 | 112 | 0.310 |
Why?
|
| Desmoplakins | 2 | 2022 | 24 | 0.310 |
Why?
|
| Infant, Newborn | 17 | 2025 | 6464 | 0.310 |
Why?
|
| Immunoglobulin E | 4 | 2020 | 315 | 0.310 |
Why?
|
| Repressor Proteins | 1 | 2013 | 429 | 0.300 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 307 | 0.300 |
Why?
|
| Proteins | 1 | 2015 | 1023 | 0.300 |
Why?
|
| Metallothionein | 1 | 2009 | 25 | 0.290 |
Why?
|
| Growth Hormone | 4 | 2001 | 91 | 0.290 |
Why?
|
| Polymorphism, Genetic | 5 | 2018 | 615 | 0.290 |
Why?
|
| Risk Factors | 14 | 2026 | 10916 | 0.280 |
Why?
|
| Microbiota | 5 | 2026 | 730 | 0.280 |
Why?
|
| Cohort Studies | 12 | 2026 | 6032 | 0.280 |
Why?
|
| Electrochemistry | 5 | 2003 | 70 | 0.280 |
Why?
|
| Thyrotropin | 4 | 1997 | 120 | 0.280 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2021 | 317 | 0.280 |
Why?
|
| Interleukin-6 | 2 | 2022 | 779 | 0.270 |
Why?
|
| Particulate Matter | 2 | 2022 | 326 | 0.270 |
Why?
|
| Particle Size | 2 | 2025 | 381 | 0.270 |
Why?
|
| Chronic Disease | 6 | 2026 | 1810 | 0.260 |
Why?
|
| Mucociliary Clearance | 2 | 2018 | 44 | 0.260 |
Why?
|
| Whole Genome Sequencing | 4 | 2023 | 178 | 0.260 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 303 | 0.260 |
Why?
|
| Pyridostigmine Bromide | 3 | 1996 | 5 | 0.260 |
Why?
|
| Fibroblasts | 4 | 2026 | 1027 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 979 | 0.250 |
Why?
|
| Acromegaly | 2 | 1997 | 17 | 0.250 |
Why?
|
| Gene Regulatory Networks | 4 | 2024 | 319 | 0.250 |
Why?
|
| RNA, Long Noncoding | 3 | 2021 | 172 | 0.250 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2019 | 69 | 0.250 |
Why?
|
| Disease Models, Animal | 10 | 2026 | 4569 | 0.240 |
Why?
|
| Phagocytosis | 3 | 2025 | 296 | 0.240 |
Why?
|
| Chemokines | 2 | 2021 | 217 | 0.240 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2026 | 18 | 0.240 |
Why?
|
| Uteroglobin | 1 | 2026 | 31 | 0.240 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 298 | 0.240 |
Why?
|
| Alkanesulfonic Acids | 2 | 2023 | 35 | 0.240 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2026 | 13 | 0.240 |
Why?
|
| Otitis Media | 2 | 2019 | 182 | 0.240 |
Why?
|
| Pulmonary Alveoli | 3 | 2025 | 387 | 0.230 |
Why?
|
| Macrophages, Alveolar | 1 | 2009 | 373 | 0.230 |
Why?
|
| Peri-Implantitis | 1 | 2025 | 1 | 0.230 |
Why?
|
| Child, Preschool | 14 | 2026 | 11866 | 0.220 |
Why?
|
| Lung Injury | 2 | 2026 | 249 | 0.220 |
Why?
|
| Epithelium | 3 | 2022 | 311 | 0.220 |
Why?
|
| Obesity | 6 | 2023 | 3118 | 0.220 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 875 | 0.220 |
Why?
|
| Adiponectin | 2 | 2024 | 242 | 0.210 |
Why?
|
| Young Adult | 15 | 2021 | 14250 | 0.210 |
Why?
|
| Soot | 1 | 2024 | 23 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2020 | 457 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2026 | 241 | 0.210 |
Why?
|
| RNA Splicing | 1 | 2026 | 284 | 0.210 |
Why?
|
| Dysbiosis | 1 | 2026 | 188 | 0.210 |
Why?
|
| Mothers | 4 | 2023 | 765 | 0.210 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2024 | 25 | 0.210 |
Why?
|
| Toll-Like Receptors | 2 | 2018 | 193 | 0.210 |
Why?
|
| Precision Medicine | 2 | 2026 | 461 | 0.210 |
Why?
|
| Telomere Homeostasis | 1 | 2024 | 33 | 0.200 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 49 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 6 | 2018 | 1043 | 0.200 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2023 | 32 | 0.200 |
Why?
|
| Ligaments | 1 | 2024 | 76 | 0.200 |
Why?
|
| Subtilisins | 1 | 2023 | 9 | 0.200 |
Why?
|
| Cell Line | 6 | 2021 | 2823 | 0.200 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2024 | 62 | 0.200 |
Why?
|
| Receptors, Immunologic | 2 | 2015 | 209 | 0.190 |
Why?
|
| Mast Cells | 1 | 2024 | 148 | 0.190 |
Why?
|
| Immune Tolerance | 2 | 2017 | 385 | 0.190 |
Why?
|
| Saccharopolyspora | 1 | 2022 | 6 | 0.190 |
Why?
|
| Serine Endopeptidases | 1 | 2023 | 129 | 0.180 |
Why?
|
| Hexosyltransferases | 1 | 2002 | 6 | 0.180 |
Why?
|
| Peptidyl Transferases | 1 | 2002 | 8 | 0.180 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 40 | 0.180 |
Why?
|
| Amphiregulin | 2 | 2021 | 27 | 0.180 |
Why?
|
| Infant | 11 | 2024 | 10089 | 0.180 |
Why?
|
| Oxidative Stress | 1 | 2009 | 1359 | 0.180 |
Why?
|
| Adipogenesis | 2 | 2023 | 56 | 0.180 |
Why?
|
| Longitudinal Studies | 7 | 2026 | 2967 | 0.180 |
Why?
|
| Tin Compounds | 1 | 2001 | 14 | 0.170 |
Why?
|
| Mice, 129 Strain | 2 | 2012 | 85 | 0.170 |
Why?
|
| Endotoxins | 2 | 2013 | 217 | 0.170 |
Why?
|
| Fatty Acids | 2 | 2017 | 457 | 0.170 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2001 | 43 | 0.170 |
Why?
|
| Cellular Senescence | 2 | 2026 | 226 | 0.170 |
Why?
|
| Birth Weight | 3 | 2020 | 517 | 0.170 |
Why?
|
| Rhinitis, Allergic | 1 | 2022 | 42 | 0.170 |
Why?
|
| Methylation | 1 | 2022 | 242 | 0.170 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 20 | 0.170 |
Why?
|
| Genetic Association Studies | 4 | 2020 | 371 | 0.170 |
Why?
|
| GTPase-Activating Proteins | 3 | 2023 | 81 | 0.170 |
Why?
|
| Eczema | 1 | 2022 | 66 | 0.170 |
Why?
|
| Educational Status | 1 | 2023 | 470 | 0.170 |
Why?
|
| Electron Transport Complex III | 1 | 2021 | 18 | 0.170 |
Why?
|
| Muscle Relaxation | 1 | 2001 | 28 | 0.170 |
Why?
|
| Penis | 1 | 2001 | 33 | 0.170 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 13 | 0.170 |
Why?
|
| Electron Transport Complex II | 1 | 2021 | 27 | 0.170 |
Why?
|
| Pituitary Neoplasms | 3 | 2001 | 190 | 0.170 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2001 | 10 | 0.170 |
Why?
|
| Databases, Genetic | 3 | 2013 | 238 | 0.170 |
Why?
|
| Alcoholism | 2 | 2020 | 826 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 42 | 0.170 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 10 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 17 | 0.170 |
Why?
|
| Lipid Metabolism | 3 | 2023 | 529 | 0.170 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 39 | 0.160 |
Why?
|
| Insulin | 3 | 2021 | 2516 | 0.160 |
Why?
|
| Seroconversion | 1 | 2021 | 48 | 0.160 |
Why?
|
| Telomere | 1 | 2024 | 287 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 735 | 0.160 |
Why?
|
| Blood Proteins | 2 | 2020 | 239 | 0.160 |
Why?
|
| Propensity Score | 1 | 2023 | 377 | 0.160 |
Why?
|
| Oxidants | 1 | 2001 | 99 | 0.160 |
Why?
|
| Preconception Care | 1 | 2021 | 50 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2021 | 456 | 0.160 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 153 | 0.160 |
Why?
|
| DNA, Complementary | 4 | 2005 | 273 | 0.160 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 92 | 0.160 |
Why?
|
| Algorithms | 5 | 2023 | 1850 | 0.160 |
Why?
|
| Parturition | 1 | 2020 | 69 | 0.160 |
Why?
|
| Farmers | 1 | 2021 | 71 | 0.160 |
Why?
|
| Child Development | 1 | 2025 | 483 | 0.150 |
Why?
|
| Respiratory Function Tests | 3 | 2021 | 544 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2020 | 192 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 264 | 0.150 |
Why?
|
| Cluster Analysis | 4 | 2022 | 501 | 0.150 |
Why?
|
| Oligonucleotides | 1 | 2000 | 153 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2021 | 159 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2020 | 251 | 0.150 |
Why?
|
| Diet | 3 | 2022 | 1278 | 0.150 |
Why?
|
| Phospholipids | 1 | 2021 | 214 | 0.150 |
Why?
|
| Genetic Markers | 3 | 2021 | 338 | 0.150 |
Why?
|
| Autoantibodies | 2 | 2024 | 1509 | 0.150 |
Why?
|
| Histones | 3 | 2022 | 666 | 0.150 |
Why?
|
| Spleen | 2 | 2012 | 508 | 0.150 |
Why?
|
| Chromosome Mapping | 2 | 2011 | 507 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2021 | 1218 | 0.150 |
Why?
|
| Adenine | 1 | 2002 | 339 | 0.150 |
Why?
|
| alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
|
| Stomach Neoplasms | 1 | 2001 | 128 | 0.150 |
Why?
|
| ERG1 Potassium Channel | 1 | 2018 | 6 | 0.140 |
Why?
|
| Interleukin-5 Receptor alpha Subunit | 1 | 2018 | 6 | 0.140 |
Why?
|
| Sleep Medicine Specialty | 1 | 2019 | 10 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2020 | 3752 | 0.140 |
Why?
|
| Neoplasms | 2 | 2013 | 2913 | 0.140 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2019 | 71 | 0.140 |
Why?
|
| Cells, Cultured | 5 | 2021 | 4151 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 534 | 0.140 |
Why?
|
| Linkage Disequilibrium | 3 | 2016 | 255 | 0.140 |
Why?
|
| Software | 3 | 2013 | 680 | 0.140 |
Why?
|
| Nitric Oxide | 2 | 2014 | 892 | 0.140 |
Why?
|
| Pulmonary Medicine | 1 | 2019 | 78 | 0.140 |
Why?
|
| Eosinophils | 2 | 2018 | 316 | 0.140 |
Why?
|
| Paraquat | 1 | 2018 | 13 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 625 | 0.130 |
Why?
|
| Swine | 3 | 2014 | 826 | 0.130 |
Why?
|
| Phthalic Acids | 1 | 2018 | 42 | 0.130 |
Why?
|
| Herbicides | 1 | 2018 | 27 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 45 | 0.130 |
Why?
|
| Prolactin | 2 | 1995 | 87 | 0.130 |
Why?
|
| Rhinitis | 1 | 2020 | 169 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2018 | 36 | 0.130 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 41 | 0.130 |
Why?
|
| Diagnosis | 1 | 1997 | 16 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 47 | 0.130 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 47 | 0.130 |
Why?
|
| Body Mass Index | 3 | 2021 | 2447 | 0.130 |
Why?
|
| Binding Sites | 3 | 2021 | 1311 | 0.130 |
Why?
|
| Health Status | 1 | 2023 | 835 | 0.130 |
Why?
|
| Mutation | 5 | 2022 | 4090 | 0.130 |
Why?
|
| Dissection | 1 | 2017 | 57 | 0.130 |
Why?
|
| Adolescent | 13 | 2026 | 22569 | 0.130 |
Why?
|
| Jejunum | 1 | 2017 | 37 | 0.130 |
Why?
|
| Systems Biology | 1 | 2017 | 69 | 0.130 |
Why?
|
| Human Growth Hormone | 1 | 1997 | 47 | 0.130 |
Why?
|
| Clostridium Infections | 1 | 2018 | 74 | 0.130 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 139 | 0.130 |
Why?
|
| Patient Outcome Assessment | 1 | 2018 | 130 | 0.120 |
Why?
|
| Complement C3 | 1 | 2018 | 187 | 0.120 |
Why?
|
| Environmental Health | 1 | 2017 | 40 | 0.120 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2017 | 70 | 0.120 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 94 | 0.120 |
Why?
|
| Caspases | 2 | 2011 | 233 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2019 | 618 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1512 | 0.120 |
Why?
|
| PPAR gamma | 2 | 2017 | 182 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2021 | 584 | 0.120 |
Why?
|
| Air Microbiology | 1 | 2016 | 37 | 0.120 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 132 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2011 | 1454 | 0.120 |
Why?
|
| Bronchi | 1 | 2018 | 263 | 0.120 |
Why?
|
| Volatile Organic Compounds | 1 | 2016 | 47 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 143 | 0.120 |
Why?
|
| Omalizumab | 1 | 2016 | 43 | 0.120 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2016 | 58 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 361 | 0.120 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2016 | 74 | 0.120 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 159 | 0.120 |
Why?
|
| Arachis | 1 | 2017 | 108 | 0.120 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 8346 | 0.120 |
Why?
|
| ADAMTS9 Protein | 1 | 2015 | 5 | 0.120 |
Why?
|
| Serpin E2 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2015 | 7 | 0.120 |
Why?
|
| Proteome | 3 | 2025 | 514 | 0.120 |
Why?
|
| ADAMTS4 Protein | 1 | 2015 | 16 | 0.120 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2015 | 19 | 0.120 |
Why?
|
| Lipids | 1 | 2021 | 707 | 0.120 |
Why?
|
| Liver | 3 | 2012 | 1899 | 0.120 |
Why?
|
| Gene Frequency | 3 | 2022 | 489 | 0.110 |
Why?
|
| Serpins | 1 | 2015 | 28 | 0.110 |
Why?
|
| Vital Capacity | 3 | 2012 | 292 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2023 | 8075 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 504 | 0.110 |
Why?
|
| E-Selectin | 1 | 2015 | 61 | 0.110 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2015 | 33 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 1261 | 0.110 |
Why?
|
| Galectins | 1 | 2015 | 26 | 0.110 |
Why?
|
| Fungi | 1 | 2016 | 121 | 0.110 |
Why?
|
| Oncogenes | 1 | 1996 | 118 | 0.110 |
Why?
|
| HLA-DRB1 Chains | 1 | 2016 | 110 | 0.110 |
Why?
|
| GTP-Binding Proteins | 1 | 1996 | 153 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2015 | 64 | 0.110 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1995 | 47 | 0.110 |
Why?
|
| Ligands | 2 | 2022 | 668 | 0.110 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2015 | 6 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2017 | 188 | 0.110 |
Why?
|
| Transcription Factors | 6 | 2024 | 1736 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 1482 | 0.110 |
Why?
|
| Peanut Hypersensitivity | 1 | 2017 | 143 | 0.110 |
Why?
|
| Drosophila | 1 | 2016 | 166 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 185 | 0.110 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2015 | 22 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2016 | 484 | 0.110 |
Why?
|
| Pedigree | 4 | 2019 | 515 | 0.110 |
Why?
|
| Cross-Sectional Studies | 6 | 2025 | 5921 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 968 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 185 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 337 | 0.110 |
Why?
|
| Staphylococcus aureus | 2 | 2016 | 453 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2013 | 1184 | 0.110 |
Why?
|
| Acute Disease | 2 | 2012 | 1036 | 0.110 |
Why?
|
| Infant, Premature | 1 | 2019 | 620 | 0.110 |
Why?
|
| Glucose | 2 | 1997 | 1048 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 2191 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2014 | 69 | 0.100 |
Why?
|
| Interleukin-4 | 1 | 2015 | 207 | 0.100 |
Why?
|
| Allergens | 1 | 2017 | 386 | 0.100 |
Why?
|
| Interleukin-13 | 1 | 2015 | 146 | 0.100 |
Why?
|
| Bronchoscopy | 2 | 2020 | 227 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2026 | 309 | 0.100 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2013 | 12 | 0.100 |
Why?
|
| Aspartic Acid | 1 | 2014 | 88 | 0.100 |
Why?
|
| Untranslated Regions | 1 | 2013 | 3 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2016 | 260 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 247 | 0.100 |
Why?
|
| Membrane Proteins | 4 | 2017 | 1166 | 0.100 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 65 | 0.100 |
Why?
|
| Oxidation-Reduction | 4 | 2017 | 1068 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 203 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 49 | 0.100 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 227 | 0.100 |
Why?
|
| RNA, Neoplasm | 2 | 2004 | 83 | 0.100 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 507 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 546 | 0.100 |
Why?
|
| Models, Statistical | 1 | 1997 | 672 | 0.100 |
Why?
|
| Prognosis | 4 | 2026 | 4329 | 0.100 |
Why?
|
| APACHE | 1 | 2013 | 68 | 0.090 |
Why?
|
| Chondrosarcoma | 1 | 2013 | 17 | 0.090 |
Why?
|
| Klebsiella Infections | 1 | 2013 | 26 | 0.090 |
Why?
|
| Glycine | 1 | 2014 | 186 | 0.090 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2012 | 13 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 372 | 0.090 |
Why?
|
| Escherichia coli | 2 | 2011 | 835 | 0.090 |
Why?
|
| Critical Care | 1 | 2019 | 702 | 0.090 |
Why?
|
| Myocardium | 1 | 2018 | 935 | 0.090 |
Why?
|
| Bacterial Infections | 2 | 2013 | 246 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2014 | 354 | 0.090 |
Why?
|
| Introns | 1 | 2013 | 256 | 0.090 |
Why?
|
| Neutrophils | 2 | 2024 | 1125 | 0.090 |
Why?
|
| Latin America | 1 | 2012 | 96 | 0.090 |
Why?
|
| Exons | 1 | 2013 | 364 | 0.090 |
Why?
|
| Carbon Monoxide | 1 | 2012 | 82 | 0.090 |
Why?
|
| Colorado | 5 | 2021 | 4556 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2025 | 2770 | 0.090 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2012 | 50 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 393 | 0.090 |
Why?
|
| Caspases, Initiator | 1 | 2011 | 16 | 0.090 |
Why?
|
| Blood Coagulation Factors | 1 | 2012 | 71 | 0.090 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2011 | 30 | 0.090 |
Why?
|
| Electrodes | 2 | 2002 | 111 | 0.090 |
Why?
|
| Agriculture | 1 | 2012 | 94 | 0.080 |
Why?
|
| Inhalation Exposure | 1 | 2012 | 103 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2012 | 166 | 0.080 |
Why?
|
| Poly I-C | 1 | 2011 | 58 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 59 | 0.080 |
Why?
|
| Research Design | 1 | 1997 | 1139 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 2028 | 0.080 |
Why?
|
| Escherichia coli Infections | 1 | 2011 | 125 | 0.080 |
Why?
|
| Mice, Inbred C3H | 1 | 2010 | 254 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2014 | 848 | 0.080 |
Why?
|
| Interferon-gamma | 2 | 2021 | 784 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2018 | 3130 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2017 | 2344 | 0.080 |
Why?
|
| Dust | 3 | 2018 | 92 | 0.080 |
Why?
|
| Saskatchewan | 2 | 2021 | 8 | 0.080 |
Why?
|
| Fibrosis | 2 | 2023 | 561 | 0.080 |
Why?
|
| Proteomics | 4 | 2025 | 1188 | 0.080 |
Why?
|
| Cross Infection | 1 | 2013 | 260 | 0.080 |
Why?
|
| Exome | 2 | 2023 | 229 | 0.080 |
Why?
|
| Gain of Function Mutation | 2 | 2021 | 35 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 838 | 0.080 |
Why?
|
| Chemokine CXCL1 | 1 | 2009 | 76 | 0.080 |
Why?
|
| A549 Cells | 2 | 2021 | 75 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2026 | 5428 | 0.070 |
Why?
|
| Adenoma | 3 | 2005 | 218 | 0.070 |
Why?
|
| Reference Values | 3 | 2002 | 798 | 0.070 |
Why?
|
| Hyperacusis | 1 | 2009 | 9 | 0.070 |
Why?
|
| beta Catenin | 1 | 2011 | 254 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2025 | 322 | 0.070 |
Why?
|
| Chromatin | 2 | 2025 | 553 | 0.070 |
Why?
|
| Adipocytes | 2 | 2023 | 223 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2010 | 307 | 0.070 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 2 | 2019 | 45 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2011 | 227 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 308 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 971 | 0.070 |
Why?
|
| United States | 5 | 2020 | 16122 | 0.070 |
Why?
|
| Genome | 1 | 2011 | 305 | 0.070 |
Why?
|
| Thrombosis | 1 | 2012 | 400 | 0.070 |
Why?
|
| Gestational Age | 2 | 2023 | 989 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 603 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 267 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2005 | 1450 | 0.070 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 593 | 0.070 |
Why?
|
| Registries | 2 | 2016 | 2410 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 561 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 442 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 335 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2009 | 114 | 0.060 |
Why?
|
| Telomerase | 2 | 2019 | 246 | 0.060 |
Why?
|
| Colorectal Neoplasms | 2 | 2005 | 868 | 0.060 |
Why?
|
| Folic Acid | 2 | 2019 | 198 | 0.060 |
Why?
|
| Hypertension | 1 | 2015 | 1276 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 592 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 68 | 0.060 |
Why?
|
| Chemokine CXCL12 | 1 | 2006 | 86 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2006 | 91 | 0.060 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2026 | 27 | 0.060 |
Why?
|
| Japan | 1 | 2026 | 149 | 0.060 |
Why?
|
| Ear, Middle | 2 | 2018 | 84 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2021 | 1708 | 0.060 |
Why?
|
| Apoptosis | 2 | 2026 | 2443 | 0.060 |
Why?
|
| Hypoxia | 1 | 2013 | 1199 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 107 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2004 | 187 | 0.060 |
Why?
|
| Child Health | 2 | 2018 | 154 | 0.060 |
Why?
|
| Survival Rate | 1 | 2010 | 2094 | 0.060 |
Why?
|
| Base Sequence | 2 | 2017 | 2171 | 0.060 |
Why?
|
| RNA Polymerase II | 2 | 2021 | 350 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2006 | 133 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2026 | 53 | 0.060 |
Why?
|
| Laser Capture Microdissection | 1 | 2025 | 29 | 0.060 |
Why?
|
| Reference Standards | 1 | 2006 | 177 | 0.060 |
Why?
|
| ROC Curve | 2 | 2019 | 618 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 638 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2025 | 200 | 0.050 |
Why?
|
| Kinetics | 2 | 2000 | 1568 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2025 | 122 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 2 | 2004 | 928 | 0.050 |
Why?
|
| Computational Biology | 1 | 2009 | 669 | 0.050 |
Why?
|
| Carcinoma | 2 | 2005 | 227 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2015 | 1378 | 0.050 |
Why?
|
| Alleles | 3 | 2014 | 896 | 0.050 |
Why?
|
| Myofibroblasts | 1 | 2026 | 149 | 0.050 |
Why?
|
| Cattle | 2 | 2012 | 946 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2025 | 173 | 0.050 |
Why?
|
| K562 Cells | 1 | 2024 | 92 | 0.050 |
Why?
|
| Korea | 3 | 2001 | 18 | 0.050 |
Why?
|
| Age of Onset | 1 | 2026 | 557 | 0.050 |
Why?
|
| Oligonucleotide Probes | 1 | 2003 | 48 | 0.050 |
Why?
|
| Electrons | 2 | 2001 | 80 | 0.050 |
Why?
|
| Administration, Inhalation | 3 | 2013 | 571 | 0.050 |
Why?
|
| Metabolomics | 2 | 2021 | 733 | 0.050 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2026 | 280 | 0.050 |
Why?
|
| Genes, APC | 1 | 2003 | 11 | 0.050 |
Why?
|
| Colonic Neoplasms | 2 | 2003 | 258 | 0.050 |
Why?
|
| Fibronectins | 1 | 2024 | 136 | 0.050 |
Why?
|
| Alkanesulfonates | 1 | 2023 | 6 | 0.050 |
Why?
|
| Actins | 1 | 2026 | 427 | 0.050 |
Why?
|
| Academic Success | 1 | 2023 | 30 | 0.050 |
Why?
|
| Carboxylic Acids | 1 | 2023 | 31 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2023 | 6 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2025 | 508 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2023 | 128 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 3416 | 0.050 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 177 | 0.050 |
Why?
|
| Gold | 1 | 2003 | 116 | 0.050 |
Why?
|
| Uterus | 1 | 2024 | 228 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 322 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 2933 | 0.050 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2022 | 89 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 166 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2018 | 741 | 0.050 |
Why?
|
| Biofilms | 1 | 2025 | 292 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2026 | 558 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2004 | 119 | 0.050 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 2002 | 1 | 0.040 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2002 | 2 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3551 | 0.040 |
Why?
|
| Logistic Models | 2 | 2019 | 2139 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2022 | 58 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 105 | 0.040 |
Why?
|
| Tyrphostins | 1 | 2021 | 18 | 0.040 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 1 | 2001 | 3 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2023 | 228 | 0.040 |
Why?
|
| Immunity | 1 | 2022 | 140 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2021 | 68 | 0.040 |
Why?
|
| Eosinophil Cationic Protein | 1 | 2021 | 9 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2021 | 67 | 0.040 |
Why?
|
| Base Pair Mismatch | 1 | 2001 | 10 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2001 | 49 | 0.040 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2001 | 3 | 0.040 |
Why?
|
| Receptors, Neuropeptide | 1 | 2001 | 6 | 0.040 |
Why?
|
| CD55 Antigens | 1 | 2021 | 29 | 0.040 |
Why?
|
| Keratin-5 | 1 | 2021 | 44 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 2002 | 111 | 0.040 |
Why?
|
| Triglycerides | 1 | 2023 | 520 | 0.040 |
Why?
|
| Propylthiouracil | 1 | 2001 | 6 | 0.040 |
Why?
|
| Chemokine CXCL9 | 1 | 2021 | 38 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2001 | 71 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2005 | 2000 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 421 | 0.040 |
Why?
|
| Antithyroid Agents | 1 | 2001 | 12 | 0.040 |
Why?
|
| Dyspnea | 1 | 2023 | 250 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2021 | 65 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 1474 | 0.040 |
Why?
|
| Potentiometry | 1 | 2000 | 4 | 0.040 |
Why?
|
| Tennessee | 1 | 2020 | 57 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2001 | 22 | 0.040 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 11 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 887 | 0.040 |
Why?
|
| Haplotypes | 2 | 2014 | 500 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.040 |
Why?
|
| Seasons | 1 | 2023 | 538 | 0.040 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2021 | 55 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2000 | 31 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 2000 | 58 | 0.040 |
Why?
|
| Tripartite Motif Proteins | 1 | 2020 | 39 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 331 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 34 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2001 | 160 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 103 | 0.040 |
Why?
|
| Ruthenium | 1 | 2000 | 33 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2020 | 52 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 119 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 103 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 432 | 0.040 |
Why?
|
| Lung, Hyperlucent | 1 | 2000 | 1 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 849 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 2020 | 43 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2001 | 277 | 0.040 |
Why?
|
| Fishes | 1 | 2000 | 110 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 231 | 0.040 |
Why?
|
| HLA-DR4 Antigen | 1 | 2020 | 74 | 0.040 |
Why?
|
| Testis | 1 | 2000 | 162 | 0.040 |
Why?
|
| HLA-DR3 Antigen | 1 | 2020 | 76 | 0.040 |
Why?
|
| Keratin-15 | 1 | 2019 | 16 | 0.040 |
Why?
|
| Quinazolines | 1 | 2021 | 266 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 191 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 30 | 0.040 |
Why?
|
| Colloids | 1 | 2019 | 59 | 0.040 |
Why?
|
| Philippines | 1 | 2019 | 51 | 0.040 |
Why?
|
| Pakistan | 1 | 2019 | 79 | 0.040 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2001 | 138 | 0.040 |
Why?
|
| Finland | 1 | 2019 | 78 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 206 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 1049 | 0.040 |
Why?
|
| Virus Physiological Phenomena | 1 | 2018 | 9 | 0.040 |
Why?
|
| Expectorants | 1 | 2018 | 23 | 0.040 |
Why?
|
| Exoribonucleases | 1 | 2019 | 43 | 0.040 |
Why?
|
| Pneumonia | 2 | 2020 | 636 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 362 | 0.040 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 102 | 0.040 |
Why?
|
| Incidence | 2 | 2023 | 2933 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2019 | 117 | 0.040 |
Why?
|
| Developing Countries | 1 | 2021 | 317 | 0.030 |
Why?
|
| COS Cells | 1 | 2018 | 177 | 0.030 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2018 | 47 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 426 | 0.030 |
Why?
|
| Ribotyping | 1 | 2018 | 1 | 0.030 |
Why?
|
| Sri Lanka | 1 | 2018 | 7 | 0.030 |
Why?
|
| Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2021 | 527 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2018 | 16 | 0.030 |
Why?
|
| Environmental Pollution | 1 | 2018 | 21 | 0.030 |
Why?
|
| Comorbidity | 2 | 2016 | 1662 | 0.030 |
Why?
|
| Community-Acquired Infections | 1 | 2020 | 177 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2023 | 789 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 159 | 0.030 |
Why?
|
| Perilipin-1 | 1 | 2017 | 16 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2019 | 136 | 0.030 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2017 | 7 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2021 | 635 | 0.030 |
Why?
|
| Prevalence | 2 | 2019 | 2874 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2018 | 117 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 119 | 0.030 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2017 | 27 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
|
| Betaine | 1 | 2018 | 67 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2021 | 447 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2002 | 729 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 821 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 12 | 0.030 |
Why?
|
| Maternal Health | 1 | 2018 | 50 | 0.030 |
Why?
|
| Cell Size | 1 | 2017 | 93 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2001 | 305 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 782 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2018 | 139 | 0.030 |
Why?
|
| Myosins | 1 | 2018 | 132 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1330 | 0.030 |
Why?
|
| Demethylation | 1 | 2017 | 4 | 0.030 |
Why?
|
| Collagen | 1 | 2020 | 457 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 76 | 0.030 |
Why?
|
| Biometry | 1 | 1997 | 66 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2018 | 123 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2017 | 79 | 0.030 |
Why?
|
| Integrases | 1 | 2018 | 122 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 139 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2017 | 93 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2017 | 70 | 0.030 |
Why?
|
| Solid Phase Microextraction | 1 | 2016 | 7 | 0.030 |
Why?
|
| New Jersey | 1 | 2016 | 16 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 435 | 0.030 |
Why?
|
| Parasympathomimetics | 1 | 1996 | 3 | 0.030 |
Why?
|
| Muscle Development | 1 | 2017 | 112 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 1329 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 926 | 0.030 |
Why?
|
| Breast Diseases | 1 | 1996 | 23 | 0.030 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2017 | 121 | 0.030 |
Why?
|
| Group Processes | 1 | 2017 | 63 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 421 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2016 | 85 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 2016 | 53 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 365 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2016 | 75 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 595 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 334 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 67 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2016 | 47 | 0.030 |
Why?
|
| Biological Assay | 1 | 2016 | 132 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 266 | 0.030 |
Why?
|
| Cyclonic Storms | 1 | 2016 | 40 | 0.030 |
Why?
|
| Forced Expiratory Volume | 2 | 2012 | 450 | 0.030 |
Why?
|
| Abscess | 1 | 1996 | 77 | 0.030 |
Why?
|
| Time Factors | 3 | 2012 | 7133 | 0.030 |
Why?
|
| Chest Pain | 1 | 2016 | 99 | 0.030 |
Why?
|
| Fetal Development | 1 | 2019 | 298 | 0.030 |
Why?
|
| Emphysema | 1 | 2016 | 100 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 217 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 142 | 0.030 |
Why?
|
| Octreotide | 1 | 1995 | 23 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2017 | 308 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 291 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 2051 | 0.030 |
Why?
|
| Headache | 1 | 2016 | 152 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2514 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2015 | 43 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 896 | 0.030 |
Why?
|
| Blood Cells | 1 | 2014 | 38 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 134 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 496 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1997 | 1300 | 0.030 |
Why?
|
| Child Welfare | 1 | 2017 | 233 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 2016 | 171 | 0.030 |
Why?
|
| Energy Intake | 1 | 2017 | 512 | 0.030 |
Why?
|
| Age Factors | 2 | 2018 | 3346 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 2015 | 108 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1139 | 0.030 |
Why?
|
| Fetus | 1 | 2019 | 804 | 0.030 |
Why?
|
| Isoleucine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2019 | 900 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1997 | 0.030 |
Why?
|
| Mexico | 1 | 2015 | 233 | 0.030 |
Why?
|
| Threonine | 1 | 2014 | 44 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 849 | 0.030 |
Why?
|
| Research | 1 | 2017 | 431 | 0.020 |
Why?
|
| Mucin 5AC | 1 | 2013 | 71 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 1083 | 0.020 |
Why?
|
| Pyroglyphidae | 1 | 2013 | 18 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1994 | 405 | 0.020 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 80 | 0.020 |
Why?
|
| Tuberculosis | 1 | 1996 | 284 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 1331 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2015 | 252 | 0.020 |
Why?
|
| DNA Probes | 1 | 2012 | 59 | 0.020 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 180 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 263 | 0.020 |
Why?
|
| Programming Languages | 1 | 2012 | 24 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 2110 | 0.020 |
Why?
|
| Multigene Family | 1 | 2013 | 210 | 0.020 |
Why?
|
| Nebraska | 1 | 2012 | 21 | 0.020 |
Why?
|
| Neck | 1 | 2013 | 109 | 0.020 |
Why?
|
| Probability | 2 | 2005 | 308 | 0.020 |
Why?
|
| Expressed Sequence Tags | 2 | 2002 | 43 | 0.020 |
Why?
|
| Cell Separation | 1 | 2013 | 306 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2005 | 688 | 0.020 |
Why?
|
| Pesticides | 1 | 2012 | 59 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 408 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 249 | 0.020 |
Why?
|
| Catalysis | 2 | 2003 | 305 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2017 | 935 | 0.020 |
Why?
|
| Antigens | 1 | 2013 | 348 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 295 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2011 | 123 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 2240 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2017 | 719 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 343 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2011 | 273 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2011 | 92 | 0.020 |
Why?
|
| Listeriosis | 1 | 2011 | 63 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 667 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 362 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 200 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2011 | 102 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 572 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 1129 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 1165 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2009 | 138 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 2525 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 2602 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17322 | 0.020 |
Why?
|
| Respiratory System | 1 | 2008 | 150 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 1925 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 2131 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 2883 | 0.010 |
Why?
|
| Models, Biological | 1 | 2013 | 1764 | 0.010 |
Why?
|
| Response Elements | 1 | 2006 | 86 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 5585 | 0.010 |
Why?
|
| Genes, DCC | 1 | 2005 | 1 | 0.010 |
Why?
|
| History, 18th Century | 1 | 2005 | 18 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2005 | 28 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 110 | 0.010 |
Why?
|
| Aging | 1 | 1996 | 1973 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2005 | 58 | 0.010 |
Why?
|
| Interferons | 1 | 2006 | 186 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 194 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 428 | 0.010 |
Why?
|
| Quality of Life | 1 | 2016 | 3210 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 200 | 0.010 |
Why?
|
| Microelectrodes | 1 | 2003 | 49 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2003 | 20 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 21 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 2002 | 18 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 43 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 295 | 0.010 |
Why?
|
| Genes | 1 | 2002 | 228 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 219 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 731 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1270 | 0.010 |
Why?
|
| HIV Infections | 1 | 1997 | 3195 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 538 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2002 | 121 | 0.010 |
Why?
|
| Public Sector | 1 | 2001 | 16 | 0.010 |
Why?
|
| Phylogeny | 1 | 2005 | 917 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 11793 | 0.010 |
Why?
|
| Isotopes | 1 | 2001 | 33 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2001 | 45 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 169 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2001 | 105 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 305 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1082 | 0.010 |
Why?
|
| Protons | 1 | 2001 | 96 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2002 | 248 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 855 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 376 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3915 | 0.010 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2000 | 43 | 0.010 |
Why?
|
| Age Distribution | 1 | 2001 | 404 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2001 | 388 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 2123 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 2000 | 82 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 777 | 0.010 |
Why?
|
| Ultrasonography, Mammary | 1 | 1996 | 17 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 782 | 0.010 |
Why?
|
| Mammography | 1 | 1996 | 166 | 0.010 |
Why?
|